Global Trends in the Burden of Ischemic Stroke Attributable to Diabetes Versus Atrial Fibrillation
BACKGROUND: Ischemic stroke (IS) related to atrial fibrillation (AF) represents a cardio-cerebral comorbidity, whereas diabetes-related IS reflects an advanced manifestation of panvascular disease. We aimed to analyze the burden trends in AF-related and diabetes-related IS, using Global Burden of Diseases 2021 data. METHODS: To quantify the burdens of AF- and diabetes-related IS, we applied the population-attributable fraction, the proportion of burden preventable by eliminating a risk factor. We calculated population-attributable fractions stratified by time, location, and age group. We analyzed the burdens using joinpoint regression, time-series projection to 2050, and age/sex-stratified. RESULTS: Globally, AF-related IS had a higher age-standardized incidence rate in 1990 but declined steadily (average annual percentage change =-0.81 [95% CI, -0.92 to -0.69]). Conversely, diabetes-related IS, despite a lower initial incidence, exhibited substantial and sustained increases (average annual percentage change=1.10 [95% CI, 1.02-1.18]). Middle-high socio-demographic index regions experienced the greatest burden from both comorbidities. In North America and Eastern Europe, the age-standardized incidence rates of AF-related IS stabilized (average annual percentage change=-1.45 [95% CI, -1.63 to -1.27]; -0.95 [95% CI, -1.06 to -0.84]), whereas the age-standardized incidence rates of diabetes-related IS continued to increase (average annual percentage change=1.18 [95% CI, 1.02-1.34]; 0.72 [95% CI, 0.56-0.88]). High body mass index emerged as a critical shared risk factor for AF, diabetes, and IS. Projections indicate a substantial increase in diabetes-related IS incidence over the next 3 decades, contrasting with minimal growth in AF-related IS. CONCLUSIONS: IS remains a critical global health challenge, primarily driven by the rising burden of diabetes-related IS. Our findings highlight the importance of age- and country-specific interventions.
Authors
- Yanming Xie (ORCID: https://orcid.org/0009-0000-0823-2226)
- James Tin Fong Zhuang (ORCID: https://orcid.org/0000-0002-4089-7217)
- Liuding Wang (ORCID: https://orcid.org/0000-0002-3527-7865)
- Tzak S. Lau (ORCID: https://orcid.org/0009-0003-3482-4489)
- Li Ma (ORCID: https://orcid.org/0000-0003-0894-7867)
- Runting Li (ORCID: https://orcid.org/0000-0002-3096-7197)
- Lelin Zhang (ORCID: https://orcid.org/0000-0003-0613-1362)
- Xiaolin Chen (ORCID: https://orcid.org/0000-0003-3172-715X)
- Walavan Sivakumar (ORCID: https://orcid.org/0000-0002-1367-2100)
- Fa Lin (ORCID: https://orcid.org/0000-0001-8705-2652)
- Mario Teo (ORCID: https://orcid.org/0000-0002-0051-3303)
- Zixiao Li (ORCID: https://orcid.org/0000-0002-4713-5418)
- Jian Lyu (ORCID: https://orcid.org/0000-0001-6518-622X)
- Yi Liu
- Xiao Liang
- Yunling Zhang
- Yifan Chen
Institutions
- North Bristol NHS Trust (GB)
- Beth Israel Deaconess Medical Center (US)
- University of Wisconsin–Madison (US)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- State Administration of Traditional Chinese Medicine of the People's Republic of China (CN)
- Queen Mary Hospital (CN)
- Beijing Tian Tan Hospital (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- Saint John's Health Center (US)
- Xiyuan Hospital (CN)
- University of Pittsburgh Medical Center (US)
- China Academy of Chinese Medical Sciences (CN)
- National Center for Clinical Laboratories (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- Stroke
- Published
- 2026-07-17
- DOI
- https://doi.org/10.1161/strokeaha.125.054141
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00